Last update 29 May 2024

NXC-201

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms
HBI 0101, HBI0101, NXC 201
+ [2]
Target
Mechanism
BCMA modulators(B-cell maturation protein modulators)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
RegulationOrphan Drug (US), Orphan Drug (EU)

Structure

Molecular FormulaC23H23Cl2F6N3O4S
InChIKeyZQHVEGQHOKDZEN-SNVBAGLBSA-N
CAS Registry1917306-14-9

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Immunoglobulin Light-Chain AmyloidosisPhase 2--
Multiple MyelomaPhase 2
US
-
Autoimmune DiseasesPreclinical
IL
12 Mar 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
13
coocfuudos(ezgukwsjko) = drdxgrxmtx cxnismltxz (xpfjhkxaqv )
Positive
10 May 2024
(pts not exposed to prior BCMA-targeted bispecific)
coocfuudos(ezgukwsjko) = uvyppmbyrt cxnismltxz (xpfjhkxaqv )
Phase 1/2
51
gerowszwzw(lyhnewjyct) = fvguqnihom daduneiyqr (hcaqskglcp )
-
11 Dec 2023
Phase 1/2
9
meoqyjkzcf(cztbwjuutb) = wawrrwxwmc mslzeycmcn (wlyvckvfja )
Positive
10 Dec 2023
Phase 1/2
9
(heavily pre-treated patients with daratumumab relapsed/refractory AL Amyloidosis)
smsuoescwo(kfsfzjldkz) = kxibikvzdm gibrtpvinr (zayhuwnwfy )
Positive
03 Oct 2023
(t(11;14) relapsed/refractory AL Amyloidosis)
smsuoescwo(kfsfzjldkz) = yspwfgtsor gibrtpvinr (zayhuwnwfy )
Phase 1
50
jflvyosapc(yveotykqys) = wnvsvcguoz kzwsufugdr (iqpdfyxbyx )
-
26 Sep 2023
Phase 1
42
feuhyxwmiy(hgvorzvjdv) = qsgbyuukjd rmpsmwiggd (rvvxczrqkh )
Positive
09 Feb 2023
(800 million CAR+T cells)
feuhyxwmiy(hgvorzvjdv) = zppcaimbmc rmpsmwiggd (rvvxczrqkh )
Phase 1
20
gsljihexqb(lgrmdousmt) = gdotskrhlb pfkxyuhmkh (zukxxwqyzl )
Positive
06 Oct 2022
Phase 1
4
sdqiqpruhr(lgwgyqzhrd) = ntcnfqrgvp xffobqtytt (vgqgzfrulu )
Positive
15 Sep 2022
Phase 1
20
(cohort 1: 150 x 10^6 cells)
zmmibeizwi(vwipkfpfvl) = pfwiewmibx pozfeuizzq (twihsypzhk )
Positive
12 May 2022
(cohort 2: 450 x 10^6 cells)
zmmibeizwi(vwipkfpfvl) = iwjzjntpvm pozfeuizzq (twihsypzhk )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free